Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
NIHR Bioresource Rare Diseases, |
RCV000851818 | SCV000899802 | uncertain significance | Macrothrombocytopenia | 2019-02-01 | criteria provided, single submitter | research | |
Institute of Human Genetics, |
RCV003322614 | SCV004027737 | uncertain significance | Macrothrombocytopenia, isolated, 1, autosomal dominant | 2023-07-05 | criteria provided, single submitter | clinical testing | Criteria applied: PM1,PM2_SUP,PP3 |
Labcorp Genetics |
RCV003718287 | SCV004508478 | uncertain significance | not provided | 2023-03-14 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TUBB1 protein function. ClinVar contains an entry for this variant (Variation ID: 627090). This missense change has been observed in individual(s) with clinical features of TUBB1-related conditions (PMID: 31064749). This variant is present in population databases (rs146846923, gnomAD 0.006%). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 185 of the TUBB1 protein (p.Ala185Val). |